MAB Share Price Performance
zł7.62
-1.88 (-19.79%)
Price zł7.62
Share Pricen/a
Mabion S.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
MAB Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Mabion S.A. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Sep 15, 2026
- -3.53
- -89.85%
- -324.19%
- 59.6%
About MAB
- Founded
- 2007
- Employees
- 202
- CEO
- WebsiteView website
Mabion S.A., a biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland. It offers drug substance manufacturing, process development, analytics, and cell line development services. The company also provides medicines for cancer, autoimmune diseases, rare diseases, and other diseases. The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.
